Download fulltext HTML
L B, O., O A, M., F G, A., & A B, O. (2017). Awareness of Diabetic Retinopathy among patients with Diabetes Mellitus in Ilorin, Nigeria. Sudan Journal of Medical Sciences (SJMS), 12(2), 89-100. https://doi.org/10.18502/sjms.v12i2.919

https://doi.org/10.18502/sjms.v12i2.919

statistics

  • 1069 Abstract Views
  • 153 PDF Views
  • 0 HTML Views
  • Cited by 2 articles

authors

  • Olokoba L B
    No author data available.
  • Mahmud O A
    No author data available.
  • Adepoju F G
    No author data available.
  • Olokoba A B
    No author data available.

Published Date

  • Jul 4, 2017

Awareness of Diabetic Retinopathy among patients with Diabetes Mellitus in Ilorin, Nigeria

Sudan Journal of Medical Sciences (SJMS) / Sudan JMS: Volume 12 (2017), Issue No. 2 / Pages 89-100

Abstract

Background: Diabetic retinopathy is a major cause of blindness worldwide. The associated loss of productivity and quality of life of the patients with diabetic retinopathy will lead to additional socioeconomic burden. This study aims to determine the level of awareness of diabetic retinopathy among diabetic patients.

Materials and Methods: This hospital-based cross sectional study, was carried out at the Diabetic and Ophthalmology clinics of University of Ilorin Teaching Hospital, Nigeria from November 2011 to July 2012. A total of 365 patients had validated, semi-structured, and interviewer-administered questionnaires to obtain information on socio-demographic characteristics, clinical information and awareness of diabetic retinopathy.

Results: A total of 365 patients were enrolled, with age between 19 and 90 years, and a mean of 45.8 ±16.3 years. The male to female ratio was 1: 2.2. Ninety-nine respondents (27.1%) had no education. The majority (30.4%) had only primary education; 21.1% had tertiary; 14.5% had secondary while 6.8% had Quranic education. The mean duration of diabetes mellitus was 14.1 ±13.09 years. Of the 365 patients with diabetes mellitus, 279(76.4%) had heard that diabetes mellitus affects the eyes, while 86(23.6%) had not. Of those who had heard, 221(79.2%) heard it from health personnel, 45(16.1%) from radio/television, 25(9.0%) from internet, 23(8.2%) from books/newspapers, while 16(5.7%) heard from other sources.

Conclusion: There was a high level of awareness of diabetic retinopathy amongst the patients. However, the high level of awareness of the blinding complication of diabetes mellitus did not translate to a correspondingly high level of ocular examination for diabetic retinopathy.  

References
[1] “Report of the Expert Committee on the diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 20, no. 7, pp. 1183–1197, 1997.

[2] A. B. Olokoba, O. A. Obateru, and L. B. Olokoba, “Type 2 diabetes mellitus: a review of current trends,” Oman Medical Journal, vol. 27, no. 4, pp. 269–273, 2012.

[3] W. Iris and Y. David, “Diabetic Retinopathy: everybody’s business,” Community Eye Health, vol. 24, no. 75, pp. 1–3, 2011.

[4] Early Treatment Diabetic Retinopathy Study Research Group, “Early photocoagulation for diabetic retinopathy. ETDRS report no. 9,” Ophthalomology, vol. 98, no. 5, supplement, pp. 766–785, 1991.

[5] F. Ferris, “Early photocoagulation in patients with either type 1 or type 2 diabetes,” Trans Am Ophthalmol Soc, vol. 94, pp. 505–537, 1996.

[6] Report of WHO consultation, Prevention of Blindness from Diabetes Mellitus. 2005; November. Geneva, Switzerland.

[7] The Nigeria national blindness and visual impairment survey, 2005-2007.

[8] M. O. Araoye, Research Methodology with statistics for Health and Social sciences. 1st Ed. Nathadex publishers. Ilorin. 2003, chapter six, pp. 115-130.

[9] R. T. Erasmus, R. A. Alanamu, B. Bojuwoye, P. Oluboyo, and A. Arije, “Diabetic retinopathy in Nigerians: relation to duration of diabetes, type of treatment and degree of control.,” East African Medical Journal, vol. 66, no. 4, pp. 248–254, 1989.

[10] A. Ashaye, A. Arije, M. Kuti, B. Olusanya, E. Ayeni, and A. Fasanmade, “Retinopathy among type 2 diabetic patients seen at a tertiary hospital in Nigeria: a preliminary report,” Clin Ophthalmol, vol. 2, no. 1, pp. 103–108, 2008.

[11] C. O. Omolase, O. Adekanle, J. F. A. Owoeye, and B. O. Omolase, “Diabetic retinopathy in a Nigerian community,” Singapore Medical Journal, vol. 51, no. 1, pp.56–59, 2010.

[12] A. Lawan and T. B. Mohammed, “Pattern of diabetic retinopathy in Kano, Nigeria,” Annals of African Medicine, vol. 11, no. 2, pp. 75–79, 2012.

[13] S. N. Nwosu, “Diabetic Retinopathy in Nnewi, Nigeria,” Nigerian Journal of Ophthalmology, vol. 8, no. 1, pp. 7–10, 2000.

[14] B. O. Osuntokun, “Diabetic retinopathy in Nigerians: A study of 758 patients,” British Journal of Ophthalmology, vol. 53, no. 10, pp. 652–663, 1969.

[15] O. H. Onakpoya, A. O. Adeoye, and B. A. Kolawole, “Determinants of previous dilated eye examination among type II diabetics in Southwestern Nigeria,” European Journal of Internal Medicine, vol. 21, no. 3, pp. 176–179, 2010.

[16] M. Mumba, A. Hall, and S. Lewallen, “Compliance with eye screening examinations among diabetic patients at a Tanzanian referral hospital,” Ophthalmic Epidemiology, vol. 14, no. 5, pp. 306–310, 2007.

[17] I. Mohammed and A. M. Waziri, “Awareness of Diabetic retinopathy among diabetic patients at the Murtala Mohammed Hospital, Kano, Nigeria,” Niger Med J , vol. 50, no. 2, pp. 38–41, 2009.